Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypoxia-Ischemia, Brain | 8 | 2019 | 56 | 3.330 |
Why?
|
| Hypothermia, Induced | 7 | 2018 | 93 | 2.800 |
Why?
|
| Acetylcysteine | 8 | 2020 | 296 | 2.710 |
Why?
|
| Neuroprotective Agents | 4 | 2017 | 317 | 1.250 |
Why?
|
| Infant, Premature | 2 | 2015 | 284 | 0.810 |
Why?
|
| Motor Skills | 3 | 2017 | 88 | 0.710 |
Why?
|
| Glutathione | 2 | 2020 | 343 | 0.680 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2020 | 27 | 0.680 |
Why?
|
| Vagus Nerve Stimulation | 4 | 2022 | 61 | 0.650 |
Why?
|
| Chorioamnionitis | 2 | 2015 | 40 | 0.600 |
Why?
|
| Oxidative Stress | 2 | 2020 | 718 | 0.580 |
Why?
|
| Child Development | 2 | 2015 | 102 | 0.580 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2018 | 91 | 0.580 |
Why?
|
| Antioxidants | 2 | 2017 | 304 | 0.570 |
Why?
|
| Infant, Newborn | 9 | 2020 | 2455 | 0.570 |
Why?
|
| Calcitriol | 1 | 2017 | 106 | 0.560 |
Why?
|
| Animals, Newborn | 5 | 2020 | 396 | 0.560 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 498 | 0.480 |
Why?
|
| Motor Skills Disorders | 1 | 2014 | 7 | 0.460 |
Why?
|
| Vitamin D Deficiency | 1 | 2017 | 292 | 0.460 |
Why?
|
| Movement | 1 | 2015 | 179 | 0.450 |
Why?
|
| Placenta | 1 | 2014 | 101 | 0.450 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2020 | 346 | 0.450 |
Why?
|
| Leukocytes | 1 | 2013 | 99 | 0.440 |
Why?
|
| Chemokines | 1 | 2013 | 119 | 0.430 |
Why?
|
| Brain Injuries | 2 | 2021 | 268 | 0.420 |
Why?
|
| Time Factors | 7 | 2019 | 4655 | 0.410 |
Why?
|
| Cytokines | 2 | 2017 | 866 | 0.410 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 3 | 2022 | 40 | 0.390 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2020 | 2083 | 0.370 |
Why?
|
| Infant | 6 | 2019 | 2891 | 0.350 |
Why?
|
| Female | 14 | 2020 | 38074 | 0.330 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2009 | 154 | 0.310 |
Why?
|
| Male | 12 | 2019 | 37321 | 0.280 |
Why?
|
| Pregnancy | 4 | 2020 | 2334 | 0.270 |
Why?
|
| Stroke | 1 | 2018 | 2163 | 0.250 |
Why?
|
| Vitamin D | 2 | 2017 | 516 | 0.210 |
Why?
|
| Humans | 15 | 2022 | 68618 | 0.190 |
Why?
|
| Prospective Studies | 4 | 2022 | 3705 | 0.180 |
Why?
|
| Sex Factors | 2 | 2016 | 1266 | 0.180 |
Why?
|
| Animals | 5 | 2020 | 20881 | 0.180 |
Why?
|
| Neurological Rehabilitation | 1 | 2020 | 12 | 0.180 |
Why?
|
| Pregnancy, Animal | 1 | 2020 | 27 | 0.180 |
Why?
|
| Feeding and Eating Disorders | 1 | 2022 | 106 | 0.180 |
Why?
|
| Osmosis | 1 | 2020 | 38 | 0.180 |
Why?
|
| Naloxone | 1 | 2020 | 56 | 0.170 |
Why?
|
| Vagus Nerve | 4 | 2022 | 90 | 0.170 |
Why?
|
| Cohort Studies | 2 | 2017 | 2358 | 0.170 |
Why?
|
| Inflammation | 2 | 2017 | 1030 | 0.170 |
Why?
|
| Maternal Exposure | 1 | 2020 | 75 | 0.170 |
Why?
|
| Central Nervous System | 1 | 2020 | 107 | 0.170 |
Why?
|
| Transcranial Direct Current Stimulation | 1 | 2021 | 111 | 0.160 |
Why?
|
| Laboratories | 1 | 2019 | 44 | 0.160 |
Why?
|
| Treatment Outcome | 3 | 2017 | 7029 | 0.160 |
Why?
|
| Pediatrics | 1 | 2021 | 341 | 0.150 |
Why?
|
| Vitamin D3 24-Hydroxylase | 1 | 2017 | 24 | 0.150 |
Why?
|
| Behavior, Animal | 1 | 2020 | 470 | 0.140 |
Why?
|
| Phosphorus | 1 | 2017 | 64 | 0.140 |
Why?
|
| Maze Learning | 1 | 2017 | 138 | 0.140 |
Why?
|
| Glutamic Acid | 1 | 2020 | 332 | 0.140 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2017 | 58 | 0.140 |
Why?
|
| Motor Activity | 1 | 2020 | 621 | 0.140 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 567 | 0.140 |
Why?
|
| Mothers | 2 | 2015 | 172 | 0.140 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 2550 | 0.140 |
Why?
|
| Rats | 2 | 2020 | 5300 | 0.140 |
Why?
|
| Brain | 3 | 2021 | 2176 | 0.130 |
Why?
|
| Random Allocation | 1 | 2017 | 442 | 0.130 |
Why?
|
| Th17 Cells | 1 | 2017 | 116 | 0.130 |
Why?
|
| Memory | 1 | 2017 | 214 | 0.130 |
Why?
|
| Brain Infarction | 1 | 2016 | 54 | 0.130 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2016 | 201 | 0.130 |
Why?
|
| Caspase 3 | 1 | 2016 | 233 | 0.130 |
Why?
|
| Sex Characteristics | 1 | 2017 | 295 | 0.120 |
Why?
|
| Cell Death | 1 | 2016 | 329 | 0.120 |
Why?
|
| Head | 1 | 2015 | 59 | 0.120 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2014 | 57 | 0.120 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 244 | 0.120 |
Why?
|
| Fetal Blood | 1 | 2014 | 131 | 0.120 |
Why?
|
| Enzyme Activation | 1 | 2016 | 791 | 0.120 |
Why?
|
| Hippocampus | 1 | 2017 | 471 | 0.110 |
Why?
|
| Double-Blind Method | 2 | 2015 | 1738 | 0.110 |
Why?
|
| Infusions, Intravenous | 1 | 2014 | 334 | 0.110 |
Why?
|
| Free Radical Scavengers | 1 | 2014 | 112 | 0.110 |
Why?
|
| Leukocyte Count | 1 | 2013 | 94 | 0.110 |
Why?
|
| Biomechanical Phenomena | 1 | 2015 | 368 | 0.110 |
Why?
|
| Psychomotor Performance | 1 | 2015 | 213 | 0.110 |
Why?
|
| Developmental Disabilities | 1 | 2014 | 119 | 0.110 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2013 | 113 | 0.110 |
Why?
|
| Chemokine CCL3 | 1 | 2012 | 9 | 0.110 |
Why?
|
| Interleukin-12 | 1 | 2012 | 75 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 2223 | 0.100 |
Why?
|
| Chemokine CCL2 | 1 | 2012 | 101 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1745 | 0.100 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 517 | 0.100 |
Why?
|
| Interleukin-6 | 1 | 2012 | 330 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2014 | 1342 | 0.090 |
Why?
|
| Myelin Sheath | 1 | 2009 | 115 | 0.080 |
Why?
|
| Oligodendroglia | 1 | 2009 | 107 | 0.080 |
Why?
|
| Polysaccharides | 1 | 2009 | 176 | 0.070 |
Why?
|
| Prognosis | 1 | 2012 | 2093 | 0.070 |
Why?
|
| Risk Factors | 1 | 2017 | 5731 | 0.070 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2006 | 20 | 0.070 |
Why?
|
| Adult | 3 | 2021 | 21403 | 0.070 |
Why?
|
| Myelin Basic Protein | 1 | 2006 | 62 | 0.070 |
Why?
|
| Research Design | 1 | 2009 | 729 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2006 | 951 | 0.060 |
Why?
|
| Electromyography | 1 | 2020 | 184 | 0.040 |
Why?
|
| Metabolome | 1 | 2019 | 15 | 0.040 |
Why?
|
| Basal Ganglia | 1 | 2019 | 45 | 0.040 |
Why?
|
| Electricity | 1 | 2019 | 33 | 0.040 |
Why?
|
| Perception | 1 | 2019 | 189 | 0.040 |
Why?
|
| Electric Stimulation | 1 | 2018 | 218 | 0.040 |
Why?
|
| User-Computer Interface | 1 | 2019 | 230 | 0.040 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2021 | 413 | 0.030 |
Why?
|
| Echoencephalography | 1 | 2015 | 10 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2015 | 57 | 0.030 |
Why?
|
| Stroke Rehabilitation | 1 | 2020 | 335 | 0.030 |
Why?
|
| Fetus | 1 | 2015 | 157 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 2077 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 2015 | 296 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2015 | 418 | 0.030 |
Why?
|
| Child | 1 | 2021 | 6405 | 0.020 |
Why?
|